LATEST ARTICLES
Norway
ACAPO
Patent Litigation Comparative Guide for the jurisdiction of Norway, check out our comparative guides section to compare across multiple countries
Haavind
The Norwegian Trademark Act (Nw. Varemerkeloven) is being amended to harmonize with the EU Trademark Directive (2015/2436/EC), with changes taking effect 1 March 2023.
Wikborg Rein
Artificial intelligence, such as ChatGPT and GPT-4, is challenging the established state of the law. There are currently multiple ongoing law suits which should interest...
Barzano & Zanardo
On March 1st, 2023, the new Norwegian Trademark Act enters into force, and among the most salient changes, special relevance is given to the protection...
Advokatfirmaet Schjodt AS
In 2020, the newspaper VG published several news stories criticizing the law firm Rogstad. To illustrate the news stories, VG published photographs from Rogstad's webpage and the Facebook page of one of Rogstad's employees.
Advokatfirmaet Schjodt AS
In a final and enforceable judgment of 12 March 2021 (LF-2020-92904), Frostating Court of Appeal found there to be unlawful use of trade secrets by a former employee using his knowledge gained...
Advokatfirmaet Schjodt AS
It is crucial for early-stage life sciences companies to ensure that they have title to the inventions which they rely upon.
Kvale
The Norwegian legal system has a framework that makes it a favourable choice of jurisdiction for the litigation of patents. A specialized venue accompanied by expert lay judges forms the basis for high quality judgements.
Foley Hoag LLP
I am excited to be traveling to Norway next week to attend my first conference of the Pharmaceutical Trade Marks Group in Oslo.
Zacco
Apart from design products, such as furniture, interior lamps and tableware, there is a tendency to focus on patents and trademarks as the dominant types of IP right.
Zacco
On May 31 2013 changes were made to the Patents Act regarding damages in patent infringement cases where the infringement was found to be wilful or negligent.
Bryn Aarflot AS
We have previously asked whether Norway is the best pupil in class or if The Norwegian Industrial Property Office, despite Norway's obligations according to the European Economic Area agreement, fails to implement the same requirements of distinctiveness as the EU.
Bryn Aarflot AS
While the ONEL/OMEL decision has led to discussions on the geographical scope of use of a registered CTM, the Norwegian Industrial Property Office Board of Appeal has issued a decision referring to the quantitative requirements underlying the "genuine use" criterion.
Advokatfirmaet Grette DA
The EPO changed its guidelines in June 2012 and on the 24th of October 2012 the Norwegian Patent Office amended its patent guidelines. Here follows a brief outline of the amendments in Norway.
Advokatfirmaet Grette DA
Eight years after Norway implemented the Patent Directive (Directive 98/44/EC), and four years after the Patents Act underwent some further changes when Norway acceded to the EPC, the Norwegian Ministry of Justice (MoJ) has issued a consultation paper in which some of the implemented measures are reviewed and some amendments and adjustments are proposed.
Advokatfirmaet Grette DA
The Advocate General Jàn Mazák today delivered his opinion in the AstraZeneca case. AstraZeneca (AstraZeneca AB and AstraZeneca plc) had appealed the judgment from the General Court of the European Union of July 2010 where the European Commission’s fine for i.a. abusing the patent system was upheld, although it was reduced to 52,5 mill EURO.
Advokatfirmaet Grette DA
On 3rd May 2012, Advocate General Verica Trstenjak
issued her opinion in case C-130/11, also known as the Neurim case.
Bryn Aarflot AS
Norway (in addition to Finland) only accepted product patents on active ingredients in medicaments from 1. January 1992.
European Union
Zacco
From April, there will be more freedom in working with divisional patent applications in Europe as the abolition of the 24 month time-limit in EPO's Rule 36 enters into force.
Advokatfirmaet Grette DA
On 24th November 2011 the Court of Justice of the European Union released its important decisions in the two cases Medeva (Case C-322/10) and Georgetown (Case C-422/10).
Mondaq Webinars
FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Comparative Guides
Upcoming Events
Mondaq Advice Centres
